
Enhanced antimalarial activity of plasmepsin V inhibitors by modification of the P2 position of PEXEL peptidomimetics
Keywords: Plasmepsin; Malaria; Protease; Peptidomimetic; PEXEL; Trafficking; Abu; aminobutyric acid; Cav; canavanine; CyHexGly; cyclohexylglycine; CyPenGly; cyclopentylglycine; EtNva; beta-ethyl-norvaline; GFP; green fluorescent protein; HBTU; O-(benzotriazol-1-yl)